Perioperative heparinase rotational thromboelastometry monitoring in adult living related liver transplantation.

Not Applicable

• Conditions: Digestive System; End-stage liver disease for scheduled liver transplantation

• Registration Number: PACTR201712002839259
• Lead Sponsor: Faculty Medicine, of Menoufia University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-12-05
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

All adult patients with end stage liver disease scheduled for live adult liver transplantation were enrolled within a 2 year study period.

Exclusion Criteria

Any factor that interfere with coagulation such as patient on oral anticoagulant, or on procoagulant as activated factor seven (Novoseven).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clotting Time (CT) of heparinase ROTAM;Maximal Clot Firmness (MCF) of heparinase ROTAM

Secondary Outcome Measures

Name	Time	Method
Post-operative heparin infusion effect on ROTAM and standard coagulation tests